- Q1 2024 Galapagos NV Earnings Call TranscriptMay 03, 2024€26.78 (-2.05%)Earnings
- Full Year 2023 Galapagos NV Earnings Call TranscriptFeb 23, 2024€36.28 (+2.14%)Earnings
- Galapagos NV at ASH Meeting & Exposition TranscriptDec 10, 2023
- Q3 2023 Galapagos NV Earnings Call TranscriptNov 03, 2023€34.44 (+5.39%)Earnings
- Half Year 2023 Galapagos NV Earnings Call TranscriptAug 04, 2023€37.24 (-2.23%)Earnings
- Q1 2023 Galapagos NV Earnings Call TranscriptMay 05, 2023€35.65 (-1.71%)Earnings
- Full Year 2022 Galapagos NV Earnings Call TranscriptFeb 24, 2023€35.48 (-3.40%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Galapagos NV Q3 2022 Earnings Call and R&D Update TranscriptNov 04, 2022€47.58 (+2.08%)Earnings
- Half Year 2022 Galapagos NV Earnings Call TranscriptAug 05, 2022€55.22 (+6.19%)Earnings
- Galapagos NV to Acquire CellPoint BV and Abound Bio Inc M&A Call TranscriptJun 22, 2022
- Q1 2022 Galapagos NV Earnings Call TranscriptMay 06, 2022€56.16 (-2.09%)Earnings
- Q4 2021 Galapagos NV Earnings Call TranscriptFeb 25, 2022€59.14 (+4.27%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference TranscriptJan 13, 2022
- Q3 2021 Galapagos NV Earnings Call TranscriptNov 05, 2021€46.96 (-1.47%)Earnings
- Galapagos NV at Citi Biopharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Galapagos NV Earnings Call TranscriptAug 06, 2021€51.4 (+0.51%)Earnings
- Q1 2021 Galapagos NV Earnings Call TranscriptMay 07, 2021€61.58 (-1.42%)Earnings
- Q4 2020 Galapagos NV Earnings Call TranscriptFeb 19, 2021€67.2 (-2.61%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Galapagos NV & Gilead Sciences Inc to Announce New Commercialization and Development Agreement for Rheumatoid Arthritis Treatment Call TranscriptDec 16, 2020
- Q3 2020 Galapagos NV Earnings Call TranscriptNov 06, 2020€106.5 (-2.16%)Earnings
- Galapagos NV Inaugural Toledo Roundtable Presentation (Virtual) TranscriptOct 27, 2020
- H1 2020 Galapagos NV Earnings Call TranscriptAug 07, 2020€161.25 (+2.09%)Earnings
- Q1 2020 Galapagos NV Earnings Call TranscriptMay 08, 2020€206.4 (-1.53%)Earnings
- Q4 2019 Galapagos NV Earnings Call TranscriptFeb 21, 2020€238 (-3.05%)Earnings
- Galapagos NV at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Galapagos NV R&D Update 2019 TranscriptNov 14, 2019
- Q3 2019 Galapagos NV Earnings Call TranscriptOct 25, 2019€148.65 (+1.88%)Earnings
- Q2 2019 Galapagos NV Earnings Call TranscriptJul 26, 2019€161 (+0.63%)Earnings
- Gilead Sciences Inc and Galapagos NV Enter Into Transformative Research and Development Collaboration Call TranscriptJul 14, 2019
- Q1 2019 Galapagos NV Earnings Call TranscriptApr 26, 2019€99.82 (-0.43%)Earnings
- Q4 2018 Galapagos NV Earnings Call TranscriptFeb 22, 2019€88.8 (-0.07%)Earnings
Q3 2020 Galapagos NV Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2020 results conference call. I would now like to hand over the conference to your first speaker today, Elizabeth Goodwin. Please go ahead.
Hi, and thank you all for joining us today for our third quarter results call. I'm Elizabeth Goodwin, Investor Relations, also representing our financial reporting team to bring you this information today. This recorded audio webcast is accessible via the Galapagos website homepage and will be available for replay later on today.
Sell-side analysts and professional investors are invited to pose a question at the end of our call and can dial in using a series of numbers in our press release from last night. Here's one for Belgium, that's 3-227-933-847. The code is 8542327, and I'll repeat that right before the Q&A starts.
I'd like to move now to our forward-looking statements and remind everyone that we will be making forward-looking statements during today's webcast. These statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)